
AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own CNA Financial, you have to believe the core commercial insurance franchise can generate steady, if unspectacular, earnings while returning a meaningful slice of cash to shareholders via ordinary and occasional special dividends. The first‑quarter 2026 earnings miss, driven by a weaker combined ratio, does not rewrite that story on its own, but it does shift the near‑term focus squarely onto underwriting discipline rather than investment income tailwinds. Short‑term catalysts now hinge more on signs that recent leadership changes and underwriting hires translate into tighter pricing and better risk selection, especially after the stock’s modest pullback this year. The main risk is that higher claims frequency or severity keeps chipping away at margins, which could test both profit resilience and the perceived dependability of the dividend.
However, one underwriting risk in particular is worth watching more closely if you own the stock. CNA Financial's shares have been on the rise but are still potentially undervalued by 41%. Find out what it's worth.Explore another fair value estimate on CNA Financial - why the stock might be worth just $73.85!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com